Meta-analysis of the correlation between glioma prognosis and PD-1/ PD-L1 expression

被引：0
|
作者：
Ren, Chang-cheng [1 ]
Xu, Bo [1 ]
Wang, Min-shu [1 ]
He, Feng [1 ]
Chen, Jun-hui [1 ]
Liao, Liang [1 ]
Liang, Wu [1 ]
机构：
[1] Hubei Minzu Univ, Dept Neurosurg, Minda Hosp, Enshi 445000, Peoples R China
来源：
ASIAN JOURNAL OF SURGERY | 2023年 / 46卷 / 12期
关键词：
Glioma; Prognosis; PD-1; PD-L1;
D O I：
10.1016/j.asjsur.2023.08.057
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：5632 / 5634
页数：3
相关论文
共 50 条
  • [41] Expression and significance of PD-1 and PD-L1 in patients with recurrent spontaneous abortion A protocol for systematic review and meta-analysis
    Li, Tao
    Chen, Yihong
    Lai, Yi
    He, Guoqian
    He, Guolin
    MEDICINE, 2021, 100 (14) : E25444
  • [42] Expression of the immune checkpoint molecules PD-L1 and PD-1 in EBV-associated lymphoproliferative disorders: A meta-analysis
    Yu, Junyao
    Jin, Shenhe
    Yin, Xiufeng
    Du, Huaping
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2024, 27 (01)
  • [43] Correlation of PD-1/PD-L1 polymorphisms and expressions with clinicopathologic features and prognosis of ovarian cancer
    Tan, Dan
    Sheng, Li
    Yi, Qing-Hua
    CANCER BIOMARKERS, 2018, 21 (02) : 287 - 297
  • [44] Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors
    Janning, Melanie
    Kobus, Franca
    Babayan, Anna
    Wikman, Harriet
    Velthaus, Janna-Lisa
    Bergmann, Sonja
    Schatz, Stefanie
    Falk, Markus
    Berger, Lars-Arne
    Boettcher, Lisa-Marie
    Paesler, Sarina
    Gorges, Tobias M.
    O'Flaherty, Linda
    Hille, Claudia
    Joosse, Simon A.
    Simon, Ronald
    Tiemann, Markus
    Bokemeyer, Carsten
    Reck, Martin
    Riethdorf, Sabine
    Pantel, Klaus
    Loges, Sonja
    CANCERS, 2019, 11 (06):
  • [45] Expression pattern of PD-1/PD-L1 in primary liver cancer with clinical correlation
    Zeng, Tanlun
    Zhao, Qian
    Liu, Junyu
    Dai, Binghua
    Wang, Tengjiao
    Yang, Facai
    Liu, Hui
    Ge, Ruiliang
    Ding, Jin
    LIVER INTERNATIONAL, 2023, 43 (09) : 1995 - 2001
  • [46] Evaluation of PD-L1 biomarker for immune checkpoint inhibitor (PD-1/PD-L1 inhibitors) treatments for urothelial carcinoma patients: A meta-analysis
    Rui, Xin
    Gu, Ting-Ting
    Pan, Hua-Feng
    Zhang, Hui-Zhi
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 67 : 378 - 385
  • [47] PD-1/PD-L1 based immunochemotherapy versus chemotherapy alone for advanced esophageal squamous cell carcinoma: A meta-analysis focus on PD-L1 expression level
    Jin, Zixian
    Wang, Jiping
    Sun, Jiajing
    Zhu, Chengchu
    Zhang, Jian
    Zhang, Bo
    CANCER REPORTS, 2023, 6 (07)
  • [48] PD-L1 expression and EGFR status in advanced non-small-cell lung cancer patients receiving PD-1/PD-L1 inhibitors: a meta-analysis
    Li, Jing
    Gu, Jian
    FUTURE ONCOLOGY, 2019, 15 (14) : 1667 - 1678
  • [49] Association between PD-1 and PD-L1 Polymorphisms and the Risk of Cancer: A Meta-Analysis of Case-Control Studies
    Hashemi, Mohammad
    Karami, Shima
    Sarabandi, Sahel
    Moazeni-Roodi, Abdolkarim
    Malecki, Andrzej
    Ghavami, Saeid
    Wiechec, Emilia
    CANCERS, 2019, 11 (08)
  • [50] PD-1/PD-L1 inhibitors
    Sunshine, Joel
    Taube, Janis M.
    CURRENT OPINION IN PHARMACOLOGY, 2015, 23 : 32 - 38
12345